A review of trazodone use in psychiatric and medical conditions
- PMID: 27744763
- DOI: 10.1080/00325481.2017.1249265
A review of trazodone use in psychiatric and medical conditions
Abstract
Trazodone is an antidepressant that is FDA-approved for the treatment of depression. It has been used by mental health and primary care providers for the treatment of multiple psychiatric and medical conditions .This review describes trazodone mechanism of action, formulation, dosage and adverse effects and then summarizes the beneficial effects of trazodone in the treatment of various psychiatric and medical conditions such as major depression, as well non-approved FDA indications such as insomnia,anxiety disorders, posttraumatic stress disorder, obsessive compulsive disorder, feeding and eating disorders, substance use disorders, behavioral disturbances associated with cognitive dysfunction, sexual dysfunction, certain pain conditions, and rehabilitation after acute ischemic stroke. Despite trazodone's favorable effects in the treatment of FDA-unapproved psychiatric and medical conditions, large, randomized controlled clinical trials are still needed to confirm its efficacy in the treatment of the multiple conditions for which it is often used in clinical practice.
Keywords: Trazodone; major depressive disorder; medical conditions; pharmacology; psychiatric disorders; serotonin receptor antagonists and reuptake inhibitors.
Similar articles
-
Off-label uses of trazodone: a review.Expert Opin Pharmacother. 2012 Aug;13(12):1707-17. doi: 10.1517/14656566.2012.699523. Epub 2012 Jun 20. Expert Opin Pharmacother. 2012. PMID: 22712761 Review.
-
[Trazodone--its multifunctional mechanism of action and clinical use].Neuropsychopharmacol Hung. 2010 Dec;12(4):477-82. Neuropsychopharmacol Hung. 2010. PMID: 21220793 Review. Hungarian.
-
[Serotonin neurotrasmission and treatment options for depression].Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(11):174-177. doi: 10.17116/jnevro2017117111174-177. Zh Nevrol Psikhiatr Im S S Korsakova. 2017. PMID: 29265105 Review. Russian.
-
A review of the evidence for the efficacy and safety of trazodone in insomnia.J Clin Psychiatry. 2005 Apr;66(4):469-76. doi: 10.4088/jcp.v66n0409. J Clin Psychiatry. 2005. PMID: 15816789 Review.
-
Rediscovering trazodone for the treatment of major depressive disorder.CNS Drugs. 2012 Dec;26(12):1033-49. doi: 10.1007/s40263-012-0010-5. CNS Drugs. 2012. PMID: 23192413 Free PMC article. Review.
Cited by
-
Evaluation of sunobinop for next-day residual effects in healthy participants.Front Pharmacol. 2024 Aug 19;15:1432902. doi: 10.3389/fphar.2024.1432902. eCollection 2024. Front Pharmacol. 2024. PMID: 39224779 Free PMC article.
-
Trazodone in the Management of Major Depression Among Elderly Patients with Dementia: A Narrative Review and Clinical Insights.Neuropsychiatr Dis Treat. 2023 Dec 21;19:2817-2831. doi: 10.2147/NDT.S434130. eCollection 2023. Neuropsychiatr Dis Treat. 2023. PMID: 38155994 Free PMC article.
-
Chronic Aripiprazole and Trazodone Polypharmacy Effects on Systemic and Brain Cholesterol Biosynthesis.Biomolecules. 2023 Aug 28;13(9):1321. doi: 10.3390/biom13091321. Biomolecules. 2023. PMID: 37759721 Free PMC article.
-
Different Effects of SSRIs, Bupropion, and Trazodone on Mitochondrial Functions and Monoamine Oxidase Isoform Activity.Antioxidants (Basel). 2023 Jun 2;12(6):1208. doi: 10.3390/antiox12061208. Antioxidants (Basel). 2023. PMID: 37371937 Free PMC article.
-
Clinical profile of trazodone users in a multisetting older population: data from the Italian GeroCovid Observational study.Eur Geriatr Med. 2023 Jun;14(3):465-476. doi: 10.1007/s41999-023-00790-1. Epub 2023 May 19. Eur Geriatr Med. 2023. PMID: 37204681 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
